Histological analyses show that reduction of FOXE1 dosage results in the loss of the expected solid pattern of tumor growth [15], with the presence of empty structures resembling follicle remnants, partially filled with cells expressing thyroid markers. The gene discussed is FOXE1; the disease is neoplasm.